Epstein-Barr viral microRNAs target caspase 3

Area of Science:

• Virology
• Molecular Biology
• Oncology

Background:

• Epstein-Barr virus (EBV) is a herpesvirus linked to B cell malignancies.
• EBV expresses numerous microRNAs (miRNAs) during latency, potentially regulating host cell processes.
• Caspase 3 (CASP3), a crucial apoptosis effector, has been hypothesized as a target of EBV miRNAs.

Purpose of the Study:

• To investigate whether Caspase 3 (CASP3) is a direct target of Epstein-Barr virus (EBV) microRNAs (miRNAs).
• To identify specific EBV miRNAs that target and repress CASP3 expression.
• To elucidate the role of EBV miRNAs in regulating apoptosis during infection.

Main Methods:

• Bioinformatic analysis of the CASP3 3'-UTR to identify potential EBV miRNA binding sites.
• Luciferase reporter assays to assess the repressive activity of 12 candidate EBV miRNAs on CASP3.
• Western blot analysis to detect changes in endogenous CASP3 protein levels upon miRNA expression.

Main Results:

• Twelve EBV miRNAs were predicted to bind the CASP3 3'-UTR.
• Nine of these miRNAs significantly repressed a full-length CASP3 reporter in luciferase assays (P < 0.001).
• Three EBV miRNAs, including BART22, demonstrated repression of endogenous CASP3 protein levels.

Conclusions:

• Caspase 3 (CASP3) is confirmed as a direct target of specific Epstein-Barr virus (EBV) BART microRNAs.
• These findings highlight a mechanism by which EBV miRNAs modulate apoptosis in infected cells.
• EBV miRNAs play a significant role in regulating host cell pathways, including cell death.